Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
for Glycogen Storage Disease Type Ia
Sites in Philadelphia +8 more locations
Sponsor: Ultragenyx Pharmaceutical Inc
Sex: All·Age: 2+
Code: NCT06636383·Recruiting·Listed Oct 2024
Paid Clinical Trials in Pennsylvania
Pennsylvania has 3,479 paid clinical trials enrolling now across cities including Philadelphia, Pittsburgh and Hershey. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Pennsylvania include Penn Medicine, Children's Hospital of Philadelphia and UPMC, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
3,012 clinical trials
Get a weekly email when new trials open in Philadelphia, PA.
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
for Esophageal Squamous Cell Carcinoma
Sites in Hershey +12 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06644781·Phase 3·Recruiting·Listed Oct 2024
A Study of SGT-212 Gene Therapy in Friedreich's Ataxia
for Friedreich's Ataxia (FA)
Sites in Philadelphia +2 more locations
Sponsor: Solid Biosciences Inc.
Sex: All·Age: 18 - 40
Code: NCT07180355·Phase 1·Recruiting·Listed Sep 2025
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
for Cardiovascular Disease
Drug: Olpasiran
Sites in Philadelphia +5 more locations
Sponsor: Amgen
Sex: All·Age: 35 - 80
Code: NCT07293260·Phase 3·Recruiting·Listed Dec 2025
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
for Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Sites in Philadelphia, Pittsburgh +6 more locations
Sponsor: Amgen
Sex: Male·Age: 18+
Code: NCT07140900·Phase 1·Recruiting·Listed Aug 2025
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
for Congenital Adrenal Hyperplasia
Sites in Philadelphia +8 more locations
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All·Age: 1 - 17
Code: NCT07159841·Phase 2, Phase 3·Recruiting·Listed Sep 2025
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
for Systemic Sclerosis (SSc)
Drug: Efgartigimod PH20 SC
Sites in Philadelphia +8 more locations
Sponsor: argenx
Sex: All·Age: 18+
Code: NCT06655155·Phase 2·Recruiting·Listed Oct 2024
Data Collection Using Eko Digital Devices in a Clinical Setting
for Lung Diseases
Sites in Philadelphia +1 more location
Sponsor: Eko Devices, Inc.
Sex: All·Age: All ages
Code: NCT07227376·Recruiting·Listed Nov 2025
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
for Lymphoma
Sites in Philadelphia +7 more locations
Sponsor: Treeline Biosciences, Inc.
Sex: All·Age: 18+
Code: NCT07082803·Phase 1·Recruiting·Listed Jul 2025
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition
for X-Linked Myotubular Myopathy
Sites in Philadelphia, Pittsburgh +5 more locations
Sponsor: Astellas Gene Therapies
Sex: Male·Age: Up to 17
Code: NCT06581146·Recruiting·Listed Sep 2024
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
for Colorectal Cancer
Sites in Philadelphia, Pittsburgh +11 more locations
Sponsor: Criterium, Inc.
Sex: All·Age: 18+
Code: NCT06992258·Phase 2·Recruiting·Listed May 2025
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
for Advanced Solid Tumor
Sites in Philadelphia +4 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06803680·Phase 1·Recruiting·Listed Jan 2025
AERA Pediatrics Registry
for Dysfunction of Eustachian Tube
Sites in Philadelphia +8 more locations
Sponsor: Integra LifeSciences Corporation
Sex: All·Age: Up to 18
Code: NCT07071298·Recruiting·Listed Jul 2025
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
for Acute Myeloid Leukaemia (AML)
Sites in Philadelphia +7 more locations
Sponsor: Moleculin Biotech, Inc.
Sex: All·Age: 18 - 80
Code: NCT06788756·Phase 2, Phase 3·Recruiting·Listed Jan 2025
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
for Congenital Adrenal Hyperplasia
Sites in Philadelphia, Pittsburgh +11 more locations
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All·Age: 18 - 74
Code: NCT07144163·Phase 3·Recruiting·Listed Aug 2025
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
for Nonmuscle-invasive Bladder Cancer
Sites in Pittsburgh +8 more locations
Sponsor: ImmVira Pharma Co. Ltd
Sex: All·Age: 18+
Code: NCT06971614·Phase 2·Recruiting·Listed May 2025
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
for Esophageal Squamous Cell Carcinoma
1 location in Pittsburgh
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06780111·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
for Low-grade Upper Tract Urothelial Carcinoma
Drug: Nadofaragene Firadenovec
Sites in Philadelphia +8 more locations
Sponsor: Ferring Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06668493·Phase 1, Phase 2·Recruiting·Listed Oct 2024
A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
for Fibrodysplasia Ossificans Progressiva
Sites in Philadelphia +1 more location
Sponsor: Ipsen
Sex: All·Age: 8+
Code: NCT06089616·Recruiting·Listed Oct 2023
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
for Non-cystic Fibrosis Bronchiectasis
Sites in Pittsburgh +4 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT06603246·Phase 1·Recruiting·Listed Sep 2024
First In Human Study of CX-801 in Advanced Solid Tumors
for Solid Tumor, Adult
Sites in Pittsburgh +4 more locations
Sponsor: CytomX Therapeutics
Sex: All·Age: 18+
Code: NCT06462794·Phase 1·Recruiting·Listed Jun 2024
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
for Relapsed or Refractory Multiple Myeloma
Sites in Philadelphia +8 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05652335·Phase 1·Recruiting·Listed Dec 2022
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
for Metastatic Castration-resistant Prostate Neoplasms
Drug: Pasritamig
Sites in Philadelphia +6 more locations
Sponsor: Janssen Research & Development, LLC
Sex: Male·Age: 18+
Code: NCT05818683·Phase 1·Recruiting·Listed Apr 2023
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
for Myeloid Leukemia, Philadelphia Positive
Sites in Philadelphia +7 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 1 - 17
Code: NCT04925479·Phase 1, Phase 2·Recruiting·Listed Jun 2021
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
for Hemophilia B
Sites in Pittsburgh +3 more locations
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT06003387·Phase 3·Recruiting·Listed Aug 2023
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
for Diabetic Foot Ulcer
1 location in Philidelphia
Sponsor: BioLab Holdings
Sex: All·Age: 18+
Code: NCT07364630·Phase 4·Recruiting·Listed Jan 2026
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
for Carcinoma, Non-Small-Cell Lung
Sites in Pittsburgh +2 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06780085·Phase 2·Recruiting·Listed Jan 2025
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
for Castration-Resistant Prostatic Cancer
Sites in Pittsburgh +8 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06863272·Phase 1, Phase 2·Recruiting·Listed Mar 2025
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
for Metastatic Hepatocellular Carcinoma
Drug: Bevacizumab
Sites in Pittsburgh +6 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06427941·Phase 1·Recruiting·Listed May 2024
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
for Juvenile Psoriatic Arthritis
Drug: Secukinumab
Sites in Pittsburgh +10 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 2 - 17
Code: NCT06751238·Phase 1·Recruiting·Listed Dec 2024
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
for Primary Photoreceptor Disease
Sites in Philadelphia +4 more locations
Sponsor: BlueRock Therapeutics
Sex: All·Age: 18+
Code: NCT06789445·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
for Ventricular Tachycardia (VT)
Sites in Philadelphia +5 more locations
Sponsor: Medtronic Cardiac Ablation Solutions
Sex: All·Age: 18 - 85
Code: NCT06703489·Recruiting·Listed Nov 2024
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
for Non-small Cell Lung Cancer
Sites in Philadelphia +4 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06731907·Phase 2·Recruiting·Listed Dec 2024
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
for Leadless Pacemaker
Sites in Paoli +9 more locations
Sponsor: Biotronik, Inc.
Sex: All·Age: 18+
Code: NCT07118358·Recruiting·Listed Aug 2025
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
for Phenylketonurias
Sites in Pittsburgh +4 more locations
Sponsor: NGGT INC.
Sex: All·Age: 18 - 55
Code: NCT06332807·Phase 1, Phase 2·Recruiting·Listed Mar 2024
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
for Wound Heal
Sites in McKeesport +16 more locations
Sponsor: ConvaTec Inc.
Sex: All·Age: 18+
Code: NCT06616844·Recruiting·Listed Sep 2024
Virtue® SAB in the Treatment of Coronary ISR Trial
for Coronary Artery Disease
Sites in Philadelphia, York +13 more locations
Sponsor: Orchestra BioMed, Inc
Sex: All·Age: 18+
Code: NCT07045194·Recruiting·Listed Jul 2025
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
for Advanced/Metastatic Solid Tumors
Sites in Pittsburgh +5 more locations
Sponsor: DualityBio Inc.
Sex: All·Age: 18+
Code: NCT07141706·Phase 1·Recruiting·Listed Aug 2025
STimulation to Activate RespIration
for ARDS (Moderate or Severe)
Sites in Philadelphia +5 more locations
Sponsor: Lungpacer Medical Inc.
Sex: All·Age: 18+
Code: NCT06832306·Recruiting·Listed Feb 2025
FIBERGRAFT Aeridyan Posterolateral Fusion Study
for Degenerative Spine Disease
Sites in Philadelphia +4 more locations
Sponsor: DePuy Synthes Products, Inc.
Sex: All·Age: 18+
Code: NCT07059065·Recruiting·Listed Jul 2025